1. Home
  2. LARK vs IXHL Comparison

LARK vs IXHL Comparison

Compare LARK & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

N/A

Current Price

$26.32

Market Cap

167.8M

Sector

Finance

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.32

Market Cap

134.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LARK
IXHL
Founded
1885
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
167.8M
134.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LARK
IXHL
Price
$26.32
$0.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.1K
7.3M
Earning Date
01-28-2026
02-13-2026
Dividend Yield
2.98%
N/A
EPS Growth
38.73
N/A
EPS
2.84
N/A
Revenue
$64,367,999.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.50
N/A
Revenue Growth
12.95
N/A
52 Week Low
$21.31
$0.08
52 Week High
$29.56
$2.25

Technical Indicators

Market Signals
Indicator
LARK
IXHL
Relative Strength Index (RSI) 49.78 31.95
Support Level $25.92 $0.34
Resistance Level $27.11 $0.37
Average True Range (ATR) 0.69 0.02
MACD 0.16 -0.01
Stochastic Oscillator 61.63 9.25

Price Performance

Historical Comparison
LARK
IXHL

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: